Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Correcting Glasses Reestablish Indoor Color Vision

By HospiMedica International staff writers
Posted on 31 Mar 2015
Innovative glasses enable red-green color vision deficiency (CVD) sufferers see digital display screens and status indicator lights when performing color-based activities.

The EnChroma Cx-65 eyewear for indoor use are based on Digital Color Boost (DCB), an optical coating technology for lenses that defines a series of precise “cutouts” along the spectrum of light, removing the wavelengths that sit between the primary colors and amplifying the color signal sent to the brain. More...
DCB coatings are made from up to 100 layers of dielectric material, with each individual layer only a few nanometers thick. Due to quantum interactions at the boundaries between layers, photons passing through the coating are selectively blocked, depending on their wavelength.

The EnChroma Cx line uses a special extra-strength version of the DCB coating that removes wavelengths of light where the overlap is occurring between the red and green cone cells. By doing so, the spectral shift can be reversed, amplifying the color signal sent to the brain. The result is that colors appear to be brighter and more pure, thousands of more shades can be seen, and they can be recognized more quickly and with less confusion. EnChroma Cx eyewear are products of EnChroma (Berkley, CA, USA), and are available as sunglasses as well.

“A lot of EnChroma sunglass wearers wanted an indoor version so they could bring the experience of seeing certain colors for the first time to their lives at work and at home,” said Tony Dykes, CEO of EnChroma. “Everything from learning at school or presenting a colorful slide show at work, to debating friends about the infamous 'gold-and-white or black-and-blue dress,' is much easier with EnChroma Cx indoor glasses.”

Red-green color blindness is caused by a genetic defect carried on the X-chromosome; the condition affects 8% of males and 0.4% of females. There are two types of red-green color blindness; deutans, which are 75% of cases, have a defect in the green cone cells; the defect causes the green cone cell to be spectrally shifted towards red (green becomes more like yellow). Protans, which are 25% of cases, have a defect in the red cone cells which causes the red cone cell to be spectrally shifted towards green (red becomes darker and more like orange).

Related Links:

EnChroma



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Silver Member
ECG Management System
NEMS Web
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.